Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what innovations are still expected.
Vanessa Slowey
Advertisement
Vanessa Slowey, president and CEO, TelyRx
Articles by Vanessa Slowey
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
3
Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D
4
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
5